Skip to content
AwardedRomaniaGoodsFramework agreement

acord cadru de furnizare medicamente din grupa" Antineoplazice si imunomodulatoare"- 2 LOTURI- atezolizumab, CEMIPLIMAB

Published
Published 6 October 2025

Overview

ACORD CADRU DE FURNIZARE medicamente din grupa Antineoplazice si imunomodulatoare"-2LOTURI -atezolizumab, CEMIPLIMAB, detaliat in caietul de sarcini si in sectiunea loturi. Autoritatea contractanta va raspunde tuturor solicitarilor de clarificari in a 13 -a zi, inainte de data limita de depunere a ofertelor. Numar zile pana la care se pot solicita clarificari inainte de data limita de depunere a ofertelor /candidaturilor- 20.

Key details

Country
Romania
Status
Awarded
Category
Goods
Procedure
Open
Contract type
Framework agreement
Published
6 October 2025
Classification (CPV)
Antineoplastic and immunomodulating agents

Award outcome

Awarded value
RON 4,009,623
Award date
1 August 2025
Contract period
— → 23 October 2025
Winners
  • ALLIANCE HEALTHCARE ROMANIA
  • DONA. LOGISTICA
  • EUROPHARM HOLDING
  • FARMEXIM S.A.
  • MEDIPLUS EXIM

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    6 October 2025

  2. Contract Award Notice

    15 July 2024

  3. Contract Award Notice

    17 April 2024

  4. Contract Award Notice

    12 April 2024

  5. Contract Award Notice

    19 January 2024

  6. Contract Award Notice

    16 January 2024

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: acord cadru de furnizare medicamente din grupa" Antineoplazice si imunomodulatoare"- 2 LOTURI- atezolizumab, CEMIPLIMAB — won by ALLIANCE HEALTHCARE ROMANIA +4 — Skim